The Cardiovascular Effects of Long COVID (E18) ft. Prof Erica Spatz скачать в хорошем качестве

The Cardiovascular Effects of Long COVID (E18) ft. Prof Erica Spatz

In this must-listen episode of Long COVID The Answers, host Funmi dives deep with expert Erica into a groundbreaking study that reveals COVID-19 may elevate the risk of heart attack and stroke for up to three years after infection, especially for people with non-O blood types. Could COVID-19 be as serious a heart disease risk factor as smoking or high cholesterol? Erica shares eye-opening insights on how the virus impacts cardiovascular health and explores innovative recovery strategies tailored to long COVID patients. Join us for this essential conversation that could redefine how we understand COVID's long-term effects on the heart. https://longcovidtheanswers.com/ Guest – Prof Erica Spatz Note: The podcast has no bias. All conflicts of interest are highlighted with individual guests. This podcast is CERTIFED CONTINUED PROFESSIONAL DEVELOPMENT CPD/CME. Healthcare Professionals and can earn 0.5 MainPro+ Credits! Please register at https://longcovidtheanswers.com/cpd-r... and watch via the CPD/ CEU dashboard area to claim your credits. #cardiovascular #longcovid #longhauler #longcovidtheanswers #longcovidrecovery REFERENCES: Professor Erica Spatz MD talks to Dr Funmi Okunola MD about the effects of Long COVID on the heart. Professor Spatz is a cardiologist and clinical investigator at the Centre for Outcomes Research and Evaluation. She is the Associate Professor of Cardiology and Associate Professor of Epidemiology at Yale School of Medicine in the USA and is the Director of the Preventative Cardiovascular Health Program. REFERENCES 1.Shah SM, Odanovic N, Kunnirickal S, Feher A, Pfau SE, Spatz ES. Chest pain and coronary endothelial dysfunction after recovery from COVID‐19: A case series. Clinical Case Reports. 2022 Apr;10(4):e05612. 2.HilserJR, Spencer NJ, Afshari K, Gilliland FD, Hu H, Deb A, Lusis AJ, Wilson Tang WH, Hartiala JA, Hazen SL, Allayee H. COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type. Arteriosclerosis, Thrombosis, and Vascular Biology. 2024 Nov;44(11):2321-33.